OverviewChartNewsTraderScreen

Organovo Holdings/  US68620A2033  /

IEX
2024-09-19  9:48:11 PM Chg. - Volume Bid- Ask- High Low
0.49USD - 480
Turnover: 245.19		 -Bid Size: - -Ask Size: - 0.52 0.49
GlobeNewswire 07-16 Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical ...
GlobeNewswire 05-21 Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Co...
GlobeNewswire 05-14 Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)
GlobeNewswire 05-09 Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
GlobeNewswire 04-15 Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohep...
GlobeNewswire 01-25 Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Functi...
GlobeNewswire 01-09 Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress
GlobeNewswire 2023-12-06 Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results
GlobeNewswire 2023-11-13 CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan
GlobeNewswire 2023-11-08 Organovo Highlights FXR314 Combination Therapy Potential and Plan
GlobeNewswire 2023-09-08 Organovo to Participate in the H.C. Wainwright Global Investment Conference
GlobeNewswire 2023-08-23 Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data
GlobeNewswire 2022-03-01 UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
GlobeNewswire 2022-02-23 Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
GlobeNewswire 2022-02-18 Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2022-02-18 Organovo Welcomes New Sr. Vice President of Strategy and Business Development
GlobeNewswire 2022-02-02 Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents
GlobeNewswire 2022-01-10 Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk
GlobeNewswire 2021-11-30 Organovo On Track to Establish Human 3D Disease Model in Inflammatory Bowel Disease in 2022
GlobeNewswire 2021-09-17 Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
GlobeNewswire 2021-03-02 Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2...
GlobeNewswire 2020-10-21 MediciNova Appoints Carolyn Beaver to its Board of Directors and as Audit Committee Chair
GlobeNewswire 2020-09-17 Cue Biopharma Welcomes Tamar Howson to its Board of Directors
GlobeNewswire 2020-09-03 Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire 2020-08-17 Organovo Announces One-for-Twenty Reverse Stock Split